Polymyxin B clinical trials
How each study uses Polymyxin B is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Polymyxin B studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 19 Apr 1954 · NEO-POLYCIN · ANDA 060647 (FDA, Drugs@FDA; in a combination)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Polymyxin B
- 5
Studies by the year they started
11 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 7
BioVersys SAS (2) · TTY Biopharm (1) · EMS (1) · National Taiwan University Hospital (1) · National University of Singapore (1) · Shanghai 10th People's Hospital (1) · University of Puerto Rico (1) · Mahidol University (1)
Often tested with
Tested in the same studies.
Neomycin (2) · BV100 (2) · Tigecycline (2) · Fosfomycin (2) · Prednisolone (1) · Benzocaine (1) · Clioquinol (1) · Bacitracin (1)
Studies
Open first, then newest update. How each study uses Polymyxin B is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- A Single Centre, Open-label, 2-period Fixed-sequence, Phase I Clinical Study to Evaluate the Effect of BV100 on the Pharmacokinetics of Polymyxin B in Healthy VolunteersRecruitingPhase 1BioVersys SASNCT07580586Written as Polymyxin B (50 mg)
- Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus ComplexRecruitingPhase 3BioVersys SASNCT07326540Written as Polymyxin B
- Sebum Metabolomics and Lipidomics for Clinical ApplicationsNot yet recruitingNot applicableNational Taiwan University HospitalNCT07549828Written as Bacitracin/Polymyxin B/Neomycin ointment (Yentuogin ointment)
- Optimising TREATment for Severe Gram-Negative Bacterial InfectionsRecruitingPhase 4National University of SingaporeNCT07004049Written as Colistin/Polymyxin B + Sulbactam
- A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal InsufficiencyCompletedPhase 1TTY BiopharmNCT05359627Written as Polymyxin B
- Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis EczematousCompletedPhase 3EMSNCT01429701Written as polymyxin B sulphate + prednisolone + benzocaine + clioquinol
- Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative BacteriaWithdrawnPhase 2/3Tan Tock Seng HospitalNCT02134106Written as Polymyxin B
- The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella PneumoniaeStatus unknownEarly Phase 1Shanghai 10th People's HospitalNCT03950544Written as Polymyxin B
- Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant PathogensStatus unknownPhase 3University of Puerto RicoNCT03159078Written as Polymyxin B
- Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative BacteriaStatus unknownPhase 4Mahidol UniversityNCT02328183Written as Polymyxin B
- Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and CurettageStatus unknownPhase 3Chulalongkorn UniversityNCT00534391Written as neomycin sulfate, polymyxin B sulfate and gramicidin
Given beside what is tested · 3 — Polymyxin B is usual care or a partner of the new treatment
- Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus ComplexNot yet recruitingPhase 2BioVersys AGNCT07431307Written as BV100 with 50 mg polymyxin B plus ceftazidime/avibactam
- Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2DActive, not recruitingPhase 1/2Atsena Therapeutics Inc.NCT03920007Written as Trimethoprim/polymyxin B
- PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRABCompletedPhase 2BioVersys AGNCT05685615Written as BV100 plus Polymyxin B
As the comparator · 1 — what is tested is compared with Polymyxin B
Codes
What other systems call Polymyxin B · ClinicalTrials.gg INT008064
- MeSH (NLM) D011112Polymyxin BConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) J2VZ07J96KPOLYMYXIN BConfirmed FDA, NLM, Wikidata
- RxNorm 8536Confirmed FDA, Wikidata
- Wikidata Q1088175polymyxin BConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61894Polymyxin BOne source FDA
- DrugBank DB00781One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011112 | Polymyxin B | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | J2VZ07J96K | POLYMYXIN B | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8536 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1088175 | polymyxin B | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61894 | Polymyxin B | One source FDA |
| DrugBank | DB00781 | — | One source Wikidata |
Also registered as polymyxin b sulfate (UNII 19371312D4 · RxNorm 388).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.